Psychedelics and Wellness Study (PAWS)
NCT04040582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3234
Last updated 2023-12-07
Summary
The Psychedelics and Wellness Study (PAWS), is an anonymous online survey investigating the interrelationship between psychedelics and wellness. The study population is adults ages 18 and older that have taken a psychedelic at least once. The maximum sample size is 5,000 survey respondents. It is expected that this anonymous online survey will support the hypothesis that there is a robust interrelationship between past psychedelic use and its impact on wellness.
Conditions
- Depression, Anxiety, PTSD
Sponsors & Collaborators
-
WILD 5 Wellness
lead OTHER
Principal Investigators
-
Saundra Jain, PsyD, LPC · WILD 5 Wellness
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-09-30
- Primary Completion
- 2023-07-25
- Completion
- 2023-07-25
Countries
- United States
Study Locations
More Related Trials
-
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
NCT05322954 ·Status: TERMINATED ·Phase: PHASE1
-
UW Psilocybin Pharmacokinetics Study
NCT02163707 ·Status: COMPLETED ·Phase: PHASE1
-
Personality and Drug Use
NCT05516823 ·Status: UNKNOWN
-
MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
NCT05709353 ·Status: RECRUITING ·Phase: PHASE2
-
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
NCT06160284 ·Status: RECRUITING ·Phase: PHASE1
-
Safety for Home Administration of Microdose Psilocybin Use
NCT06450210 ·Status: RECRUITING ·Phase: PHASE1
-
Study of the Effects of MDMA/Ecstasy on Water Regulation, Sleep, and Cognition.
NCT01053403 ·Status: COMPLETED ·Phase: NA
-
Effects of Pharmacological Stress and rTMS on Executive Function in Opioid Use Disorder
NCT04231708 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
MDMA-Assisted Therapy for Pathological Narcissism
NCT06565494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects
NCT06884514 ·Status: RECRUITING ·Phase: PHASE1
-
Behavioral Pharmacology of THC and D-limonene
NCT03609853 ·Status: COMPLETED ·Phase: PHASE1
-
Prosocial Effects of MDMA
NCT05948683 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Mood and Cognitive Effects of Psilocybin in Healthy Participants
NCT05252598 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
NCT05235503 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of Drugs on Responses to Brain and Emotional Processes
NCT04053036 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose-Response Study of MDMA-assisted Psychotherapy in People With PTSD
NCT01793610 ·Status: COMPLETED ·Phase: PHASE2
-
Additional MDMA-assisted Therapy for People Who Relapsed After MDMA-assisted Therapy Trial
NCT01458327 ·Status: COMPLETED ·Phase: PHASE2
-
How Stress Alters Opioid Drug Effects
NCT06485817 ·Status: COMPLETED ·Phase: NA
-
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
NCT06624137 ·Status: RECRUITING
-
Marijuana Cue-Reactivity & Seeking Behavior in Regular Cannabis Users
NCT03154580 ·Status: COMPLETED ·Phase: PHASE1
-
Persisting Effects of Psilocybin
NCT02971605 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
NCT03648684 ·Status: COMPLETED ·Phase: NA
-
Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC
NCT05287256 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of MDMA on Startle Response
NCT03181763 ·Status: COMPLETED ·Phase: PHASE1
-
Antidepressant Response of DMT Masked With Propofol
NCT06927076 ·Status: RECRUITING ·Phase: NA